首页> 外文OA文献 >PMS64 Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

【2h】

PMS64 Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

机译：PMS64牛皮癣关节炎患者的长期费用和结果对用肿瘤坏死因子抑制剂治疗的常规疗法无反应：牛皮癣关节炎费用评估（PACE）研究的扩展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Cortesi P.A.; Olivieri I.; de Portu S.; Salvarani C.; Cauli A.; Lubrano E.; Spadaro A.; Cantini F.; Cutro M.; Mathieu A.; Matucci-Cerinic M.; Pappone N.; Punzi L.; Scarpa R.; Mantovani L.G.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study [J] . Olivieri I., Cortesi P. A., de Portu S., Clinical and experimental rheumatology . 2016,第1期

机译：对使用肿瘤坏死因子抑制剂治疗的传统疗法无反应的银屑病关节炎患者的长期成本和结局：银屑病关节炎成本评估（PACE）研究的扩展
2. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy [J] . I. Olivieri1 S. de Portu2 C. Salvarani3 A. Cauli4 E. Lubrano5 A. Spadaro6 F. Cantini7 M. S. Cutro1 A. Mathieu4 M. Matucci-Cerinic8 N. Pappone5 L. Punzi9 R. Scarpa10 L. G. Mantovani211 and for the PACE working group Rheumatology . 2008,第11期

机译：银屑病关节炎成本评估研究：对传统疗法反应不足的银屑病关节炎患者中肿瘤坏死因子抑制剂的疾病成本研究
3. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. [J] . Olivieri I, de-Portu S, Salvarani C, Rheumatology . 2008,第11期

机译：银屑病关节炎成本评估研究：一项对传统疗法反应不足的银屑病关节炎患者中肿瘤坏死因子抑制剂的疾病成本研究。
4. Psoriatic arthritis Clinical improvement and correlation with hormone axes in etanercept-treated patients [C] . Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：依托西普治疗患者患者临床改善及与激素轴相关性
5. Costs, quality of life and mortality outcomes in United States rheumatoid arthritis patients. [D] . Michaud, Kaleb Dean. 2006

机译：美国类风湿关节炎患者的成本，生活质量和死亡率结果。
6. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy [O] . I. Olivieri, S. de Portu, C. Salvarani, -1

机译：银屑病关节炎成本评估研究：对传统疗法反应不足的银屑病关节炎患者中肿瘤坏死因子抑制剂的疾病成本研究
7. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy [O] . Olivieri, I., de Portu, S., Salvarani, C., 2008

机译：银屑病关节炎成本评估研究：对传统疗法反应不足的银屑病关节炎患者中肿瘤坏死因子抑制剂的疾病成本研究

PMS64 Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

著录项

相似文献

相关主题

期刊订阅